HUB24 Ltd (HUB)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 67.08 |
|---|---|
| 52-week range | 58.71 – 116.60 |
| Return, 1 month / 3 months | −3.4% / −19.6% |
| Return, 1 year / 3 years | −40.3% / +121.9% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -47.0% |
| Average daily value traded | 26.45M AUD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HUB24 is an Australian financial services company that runs an investment and superannuation platform used mainly by financial advisers and their clients. The platform brings together investment administration, portfolio management, reporting and compliance tools, and it also offers administration for self-managed super funds. Its customers are advice practices, brokers and individual investors who use the service to manage and track their investments in one place. The company is based in Australia.
The shares are listed on the Australian Securities Exchange in Australia under the code HUB, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HUB24 Ltd (HUB) trades on the Australian Securities Exchange in Australia. It last closed at AUD 67.08 on 20 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 826 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.3% and over the last three months it fell 19.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.9% | ||
| From 52-week high | -42.0% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.6% | ||
| 6-month return | -19.1% | ||
| 12-month return, skipping the last month | -38.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.0% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 26.45M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −3.4% |
| 3 months | −19.6% |
| 6 months | −19.1% |
| 1 year | −40.3% |
| 3 years | +121.9% |
| 5 years | +118.1% |
Signals
| 50-day / 200-day average | 71.17 / 81.73 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 2.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Sep 2026 | AUD 0.4200 |
| 16 Mar 2026 | AUD 0.3600 |
| 8 Sep 2025 | AUD 0.3200 |
| 17 Mar 2025 | AUD 0.2400 |
| 9 Sep 2024 | AUD 0.1950 |
| 18 Mar 2024 | AUD 0.1850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.